αvβ3 and α5β1 integrin-specific ligands: From tumor angiogenesis inhibitors to vascularization promoters in regenerative medicine? [electronic resource]
- Biotechnology advances
- 208-227 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1873-1899
10.1016/j.biotechadv.2017.11.004 doi
Angiogenesis Inhibitors Animals Drug Discovery Humans Integrin alpha5beta1--chemistry Integrin alphaVbeta3--chemistry Mice Neovascularization, Pathologic Regenerative Medicine Tissue Engineering